CVS Health (NYSE: CVS) today announced updates to its most common commercial template formularies that will expand the use of lower-cost biosimilars across multiple therapeutic categories, including ...

Concerns about health care affordability, intensifying scrutiny of rebate practices, and new pricing models are creating ...

CVS announced Tuesday it will expand its use of lower-cost biosimilars and tr | The move to prioritize biosimilars comes as ...

CVS Caremark will begin offering osteoporosis biosimilars Ospomyv and Stoboclo, as well as generic teriparatide, Bonsity and Tymlos. Like Humira and its biosimilars, Prolia is a specialty drug ...

Your health insurance plan includes a list called a formulary -- a directory of the drugs it covers. If you've ever been stunned at how much it cost you to fill a prescription, it’s possible that ...

May 5 () - CVS Health said on Tuesday it would prefer lower-cost, interchangeable biosimilars ‌over Johnson & Johnson's ...

That’s because drug prices and payments are negotiated as part of a package of drugs that are covered by the insurer called a ...

Laurie Wesolowicz, PharmD, director, pharmacy services clinical, Blue Cross Blue Shield of Michigan (BCBSM), says that clinical evidence and other factors can drive formulary decision-making. Evidence ...

As 2026 begins, CareFirst BCBS is implementing a suite of changes that go beyond standard annual updates, including a major ...

Over the past two decades the use of step therapy or edits by health insurers has increased significantly. Step therapy, also called step edits, implies that in a given therapeutic class lower cost ...

CVS Caremark will expand the use of lower-cost biosimilars across multiple therapeutic categories effective July 1.

WOONSOCKET, R.I., May 5, 2026 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced updates to its most common commercial template formularies that will expand the use of lower-cost biosimilars ...